Pennington James 4
4 · AzurRx BioPharma, Inc. · Filed Jul 19, 2018
Insider Transaction Report
Form 4
Pennington James
CHIEF MEDICAL OFFICER
Transactions
- Award
Options
2018-07-12+75,000→ 75,000 totalExercise: $3.04Exp: 2023-06-28→ Common Stock (75,000 underlying)
Footnotes (1)
- [F1]Options with respect to 37,500 shares vest upon the acceptance of a U.S. IND for MS 1819, and the remaining 37,500 shares vest upon the the first CF patient dosed with MS1819 anywhere in the globe.